Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Inhibition of HIV Replication and Enhancement of Immune Functions by the Acyclic Nucleoside Phosphonate 9-(2-Phosphonyl-Methoxyethyl)Adenine (PMEA) — Carlo Federico Perno (1993) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Inhibition of HIV Replication and Enhancement of Immune Functions by the Acyclic Nucleoside Phosphonate 9-(2-Phosphonyl-Methoxyethyl)Adenine (PMEA)
Shared by
De Clercq Erik
KU Leuven
Inhibition of HIV Replication and Enhancement of Immune Functions by the Acyclic Nucleoside Phosphonate 9-(2-Phosphonyl-Methoxyethyl)Adenine (PMEA)
Chapter In A Book
1993
en
Authors
+8 more
CP
Carlo Federico Perno
VG
V. Del Gobbo
JB
Jan Balzarini
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1998
Inhibitory effect of 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) on hepatitis B virus replication in vitro
Z.J. Gong
,
Sandra De Meyer
,
Chris Verslype
,
Tamara Coopmans
,
A. Soumillion
,
Johan Neyts
,
De Clercq Erik
,
S. H. Yap
Article
1995
Induction of Erythroid Differentiation of Human Leukemia K562 Cells by the Acyclic Nucleoside Phosphonate 9-(2-Phosphonylmethoxyethyl)adenine (PMEA)
Sigrid Hatse
,
Jan Balzarini
,
De Clercq Erik
Article
1998
Treatment of Visna Virus Infection in Lambs with the Acyclic Nucleoside Phosphonate Analogue 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA)
Halldór Thormar
,
G. Georgsson
,
E. Gunnarsson
,
Lieve Naesens
,
Sigurbjörg Torsteinsdóttir
,
Jan Balzarini
,
De Clercq Erik
Article
1993
Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs
Halldór Thormar
,
Jan Balzarini
,
Antonı́n Holý
,
Jindřich Jindřich
,
Ivan Rosenberg
,
Zeger Debyser
,
Jan Desmyter
,
De Clercq Erik
Article
1991
Inhibition of cytomegalovirus replication by acyclic nucleoside phosphonate analogues: structure-activity relationship
Robert Snoeck
,
A. HOLY
,
Ivan Rosenberg
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.